000			03644cam a22002534a 4500
003			OSt
005			20230830144651.0
008			050513s2006 paua b 001 0 eng
020			_a1416002731
040			_aBUL _cBUL _dBUL _beng _erda
060	1	0	_aWK 810 _bF676c 2006
100	1		_aFonseca, Vivian A.
245	1	0	_aClinical diabetes : _btranslating research into practice / _cVivian A. Fonseca.
260			_aPhiladelphia, PA : _bSaunders Elsevier, _cc2006.
300			_axxi, 661 p. : _bill. (some col.) ; _c29 cm. + _e1 CD-ROM (4 3/4 in.)
504			_aIncludes bibliographical references and index.
505			_aContents Section 1: Pathophysiology chapter 1: Scope of the problem: The diabetes and metabolic syndrome epidemic chapter 2: Type 1 Diabetes: immunology and genetics chapter 3: Type 2 Diabetes: Insulin resistance, Beta cell dysfunction and other metabolic and hormonal abnormalities chapter 4: The Biochemical consequences of hyperglycemia chapter 5: The pathogenesis and treatment of high-risk obesity chapter 6: The metabolic syndrome and its effects on cardiovascular risks chapter 7: Endothelial dysfunction in diabetes chapter 8: Diabetes and inflammation Section II : Complications chapter 9: Diabetic ketoacidosis and hyperglycemic hyperrosmolar syndrome chapter 10: Hypoglycemia in diabetes chapter 11: Diabetic Neuropathies chapter 12: Diabetic nephropathy chapter 13: Erectile dysfunction in diabetes chapter 14: The Diabetic foot chapter 15: Managing cardiovascular disease and evens in the patient with diabetes chapter 16: Diabetic retinopathy chapter 17: Diagnotic testing for coronary artery disease in diabetic patients Section III: Lifestyle management chapter 18: Primar prevention of Type 2 diabetes mellitus chapter 19: Medical nutrition therapy for type 1 and type 2 diabetes chapter 20: Diabetes education chapter 21: Stress and depression in disease chapter 22: Exercise in diabetes Section IV: Pharmacologic therapy chapter 23: Insulin secretagogues chapter 24: Insulin -sensitizing and insulin-sparing drugs chapter 25: Glucosidase inhibitors chapter 26: Type 2 Diabetes therapy: choosing oral agents chapter 27: Lip management in diabetes chapter 28: Hypertension in diabetes chapter 29: Insulin strategies in Type 1 and Type 2 Diabetes mellitus chapter 30: Beyond insulin therapy chapter 31: Pharmacologic agents and nutritional supplements in the treatment of obesity chapter 32: Physiologic insulin replacement with continuous subcutaneous insulin infusion: insulin pump therapy chapter 33: Glucose monitoring of the present and future chapter 34: Pancreas, kidney and islet transplantation: what every physician needs to know Section V: Special populations and situations chapter 35: Diabetes and pregnancy Chapter 36: Diabetes management in the hospital settling chapter 37: Diabetes mellitus in children and adolescents chapter 38: Diabetes in older adults chapter 39: Diabetes in African Americans Chapter 40: Diabetes in Latin Americans Chapter 41: Diabetes in Asians Chapter 42: New drugs and diabetes risk Section VI: Management approaches chapter 43: Running a diabetes clinic Chapter 44: Using computers and technology for diabetes care chapter 45: Pearls from major clinical trials: approaches to improving outcome of persons with diabetes
650		0	_aDiabetes.
650	1	2	_aDiabetes Mellitus _xphysiopathology.
650	2	2	_aDiabetes Mellitus _xtherapy.
650	2	2	_aEvidence-Based Medicine.
942			_2ddc _cBO _hWK 810 F676c 2006 _i1 _kWK 810 _m F676c 2006
999			_c8994 _d8994